Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis

被引:91
|
作者
Xu, W
Fazekas, G
Hara, H
Tabira, T
机构
[1] Natl Inst Longev Sci, Morioka, Obu 4748522, Japan
[2] Natl Ctr Neurol & Psychiat, Dept Demyelinating Dis & Aging, Tokyo 1878502, Japan
[3] Harbin Med Coll, Dept Immunol, Harbin 150086, Peoples R China
关键词
natural killer cells; experimental autoimmune encephalomyelitis; proteolipid protein; encephalitogenicity; cytotoxicity;
D O I
10.1016/j.jneuroim.2005.02.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis (EAE) was studied in SJL/J mice. In vivo experiments showed that NK cell depletion by anti-NK1.1 monoclonal antibody treatment enhanced EAE in mice. To investigate the mechanism, we cultured proteolipid protein (PLP)(136-150) peptide-specific, encephalitogenic T cell lines, which were used as the NK cell target. Our results show that NK cells exert a direct cytotoxic effect on autoantigen-specific, encephalitogenic T cells. Furthermore, cytotoxicity to PLP-specific, encephalitogenic T I me cells was enhanced by using enriched NK cells as effector cells. However, the cytotoxic effect of NK cells to ovalbumin-specific T line cells and ConA-stimulated T cells could also be detected with a lesser efficiency. Our studies indicate that NK cells play a regulatory role in EAE through killing of syngeneic T cells which include myelin antigen-specific, encephalitogenic T cells, and thus ameliorate EAE. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 50 条
  • [31] THE CYTOLYTIC AND REGULATORY ROLE OF NATURAL-KILLER-CELLS IN EXPERIMENTAL NEOPLASIA
    WOODRUFF, MFA
    BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 865 (01) : 43 - 57
  • [32] The role of T regulatory cells in the therapeutic effect of glatiramer acetate in experimental autoimmune encephalomyelitis
    Aharoni, R.
    Feferman, T.
    Bar Lev, D. D.
    Shakhar, G.
    Sela, M.
    Arnon, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 326 - 326
  • [33] INVIVO AND INVITRO REGULATORY ROLE OF INTERFERON-BETA ON MOUSE NATURAL-KILLER (NK) CELL-ACTIVITY
    MIGLIORATI, G
    RICCARDI, C
    GIAMPIETRI, A
    FRATI, L
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1985, 1 (03): : 205 - 210
  • [34] ADOPTIVE CELL THERAPY WITH AUTOLOGOUS INDUCED REGULATORY B CELLS IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
    Pennati, A.
    Murphy, J. R.
    Wu, Y.
    Deng, J.
    Galipeau, J.
    CYTOTHERAPY, 2015, 17 (06) : S18 - S18
  • [35] Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis
    Ochoa-Reparaz, Javier
    Riccardi, Carol
    Rynda, Agnieszka
    Jun, SangMu
    Callis, Gayle
    Pascual, David W.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (03): : 1791 - 1799
  • [36] Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis
    Wang, Zhaojun
    Qiu, Ju
    Guo, Taylor B.
    Liu, Ailian
    Wang, Ying
    Li, Yin
    Zhang, Jingwu Z.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (09): : 5958 - 5965
  • [37] The Mechanism of Effective Electroacupuncture on T Cell Response in Rats with Experimental Autoimmune Encephalomyelitis
    Liu, Yumei
    Wang, Hongwei
    Wang, Xinyue
    Mu, Lili
    Kong, Qingfei
    Wang, Dandan
    Wang, Jinghua
    Zhang, Yao
    Yang, Jinfeng
    Zhou, Mingyan
    Wang, Guangyou
    Sun, Bo
    Li, Hulun
    PLOS ONE, 2013, 8 (01):
  • [38] NATURAL-KILLER (NK) CELL LEUKEMIA
    FERNANDEZ, LA
    POPE, B
    LEE, C
    ZAYED, E
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A122 - A122
  • [39] MECHANISM OF CYTOTOXICITY BY NATURAL-KILLER (NK) CELLS
    HERBERMAN, RB
    REYNOLDS, CW
    ORTALDO, JR
    ANNUAL REVIEW OF IMMUNOLOGY, 1986, 4 : 651 - 680
  • [40] The spectrum of natural killer cell (NK) neoplasms
    Ansari, MQ
    Dawson, DB
    Picker, LJ
    McKenna, RW
    LABORATORY INVESTIGATION, 1997, 76 (01) : 694 - 694